Nivolumab treatment for relapsed/refractory Epstein-Barr virus-associated hemophagocytic lymphohistocytosis in adults
Ontology highlight
ABSTRACT: Nivolumab treatment for relapsed/refractory Epstein-Barr virus-associated hemophagocytic lymphohistocytosis in adults
PROVIDER: PRJNA576213 | ENA |
REPOSITORIES: ENA
ACCESS DATA